Data is not available at this time.
MediNet Group Limited operates as a specialized healthcare provider in Hong Kong and mainland China, focusing on integrated medical and dental services. The company generates revenue through a dual model of corporate/insurance plan memberships and self-paid patient services across its network of two medical centers, six dental clinics, and a DNA genetic laboratory. Operating in the competitive healthcare facilities sector, MediNet distinguishes itself through comprehensive service integration, offering everything from general practitioner consultations and dental care to specialized diagnostic services and genetic testing. This vertically integrated approach allows the company to capture multiple revenue streams from the same patient base while maintaining control over service quality. Their market position is strengthened by strategic corporate partnerships with insurance providers and businesses seeking comprehensive healthcare solutions for employees, creating stable recurring revenue while also serving individual consumers directly through both physical clinics and online consultation platforms.
The company generated HKD 106.4 million in revenue with net income of HKD 8.1 million, reflecting a net margin of approximately 7.6%. Operating cash flow of HKD 5.1 million demonstrates reasonable cash conversion from operations. The modest capital expenditures of HKD 292,000 indicate efficient asset utilization with limited reinvestment requirements for maintaining current operations.
MediNet exhibits moderate earnings power with diluted EPS of HKD 0.19. The company maintains positive operating cash flow generation, though capital efficiency metrics are constrained by the service-intensive nature of healthcare delivery. The business model requires ongoing investment in medical equipment and facilities to maintain service quality and competitive positioning.
The balance sheet shows HKD 13.9 million in cash against HKD 18.1 million in total debt, indicating some leverage but manageable liquidity. The debt position appears structured to support operational needs rather than aggressive expansion. The current financial structure suggests moderate financial risk with adequate cash reserves for near-term obligations.
The company maintains a conservative dividend policy with no current distributions, preferring to retain earnings for operational needs and potential expansion. Growth appears organic and measured, focusing on service depth rather than rapid network expansion. The healthcare sector's defensive characteristics provide stable demand, though growth rates remain moderate in the competitive Hong Kong market.
With a market capitalization of HKD 18.9 million, the company trades at approximately 0.18 times revenue and 2.3 times net income. The beta of 0.611 suggests lower volatility than the broader market, reflecting the defensive nature of healthcare services. Current valuation implies modest growth expectations from the market.
MediNet's integrated service model and corporate partnerships provide competitive advantages in customer retention and cross-selling opportunities. The aging population in Hong Kong supports long-term demand for healthcare services. Challenges include competitive pressure and regulatory requirements, but the company's established network and diversified service offerings position it for stable performance.
Company descriptionFinancial metrics providedHong Kong Stock Exchange filings
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |